Ciara Kennedy was appointed President and CEO of Amplyx Pharmaceuticals in 2016. Ciara is also a founder of Reneo Pharmaceuticals and Mirum Pharmaceuticals. Prior to Amplyx, Ciara served as COO at Lumena Pharmaceuticals, until the company was acquired by Shire Pharmaceuticals in June 2014. Prior to Lumena, Ciara was VP of Operations at Cypress Bioscience Inc. Prior to joining Cypress Bioscience, Ciara held several positions in the Program and Alliance department of Biogen Idec. Ciara received her doctorate at the Queen’s University of Belfast, Northern Ireland and her MBA from the Rady School of Management at UCSD.